ibuprofen

(redirected from NeoProfen)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to NeoProfen: ibuprofen

i·bu·pro·fen

 (ī′byo͞o-prō′fən)
n.
A nonsteroidal anti-inflammatory drug, C13H18O2, commonly used for its analgesic and antipyretic properties.

[Alteration of i(so)bu(tyl)phen(yl) pro(pionic acid).]

ibuprofen

(aɪbjuːˈprəʊfən)
n
(Pharmacology) a drug, isobutylphenylpropionic acid, that relieves pain and reduces inflammation: used to treat arthritis and muscular strains. Formula: C13H18O2

i•bu•pro•fen

(ˌaɪ byuˈproʊ fən)

n.
a nonsteroidal anti-inflammatory drug, C13H18O2, used esp. for reducing local pain and swelling, as of the joints.
[1965–70; isobutylphenyl propionic acid]

i·bu·pro·fen

(ī′byo͞o-prō′fən)
A medicine used to reduce fever, pain, or inflammation.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.ibuprofen - a nonsteroidal anti-inflammatory and analgesic medicine (trade names Advil and Motrin and Nuprin) used to relieve the pain of arthritis and as an antipyreticibuprofen - a nonsteroidal anti-inflammatory and analgesic medicine (trade names Advil and Motrin and Nuprin) used to relieve the pain of arthritis and as an antipyretic; "daily use of ibuprofen can irritate the stomach"
nonsteroidal anti-inflammatory, nonsteroidal anti-inflammatory drug, NSAID - an anti-inflammatory drug that does not contain steroids; "NSAIDs inhibit the activity of both Cox-1 and Cox-2 enzymes"
propanoic acid, propionic acid - a liquid fatty acid found in milk and sweat and in fuel distillates
Translations
ibuprofen

i·bu·pro·fen

n. ibuprofén, agente antiinflamatorio, antipirético y analgésico usado en el tratamiento de artritis reumatoidea.

ibuprofen

n ibuprofeno
References in periodicals archive ?
Neoprofen 100 ml, Inj Redema 10ml, Inj Paraxicam 30ml, Nimovet gel 25 g tube, etc.
When Lundbeck introduced it a few months later, it priced NeoProfen at about the same level as the post-increase price of Indocin.
for the rights to distribute ibuprofen lysine injection, the authorized generic version of NeoProfen.
NeoProfen injection is on nationwide shortage due to manufacturing issues and its manufacturer, Lundbeck, estimates a release date in the second quarter of 2012.
10 September 2010 - Danish pharma company H Lundbeck A/S (CPH: LUN) said Thursday it had won an anti-trust lawsuit in the USA regarding its acquisition of injection Neoprofen for the treatment of a congenital heart defect in premature infants.
After acquiring NeoProfen, Ovation raised the price of Indocin from $36 to nearly $500 per vial, and set a similar price when it launched NeoProfen in July 2006, according to the FTC, which has filed a civil lawsuit to force Ovation to divest itself of one of the drugs and forfeit some of the profits.
The deal--which combined Indocin IV and NeoProfen, the only two drugs to treat a potentially life threatening condition in infants--was a merger to monopoly over a product with a highly inelastic demand, and the merger was followed by price increases of nearly 1400%.
Other important products acquired in the acquisition are NeoProfen (ibuprofen lysine injection) and Indocin IV (indomethacin injection), which is indicated to close a clinically significant patent ductus arteriosus (PDA) in premature infants, and Cosmegen (dactinomycin for injection), used mainly in the treatment of three rare cancers.
22 July 2009 - The US state of Minnesota and the Federal Trade Commission have started legal proceedings against Danish pharma company H Lundbeck A/S (CPH: LUN), charging its local unit with jacking up the price of the drug Neoprofen, legal newswire Law360 reported yesterday.
bought the drug NeoProfen (ibuprofen lysine) in early 2006, when it already held the rights to Indocin IV (indomethacin).
9) In early 2006, Lundbeck acquired the rights to NeoProfen.